Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. Key Responsibilities.

Clinical Trials 52

Clinical Trials Research and Development Therapy Compliance 52

Veriheal

JULY 16, 2020

Despite the novelty of its drug policy findings, the document has gone largely unnoticed by reform advocates and the media. The panel, led by Jake Leinenkugel (a presidential nominee), asserted that psychedelics, such as MDMA and psilocybin, as well as cannabis, present promising ways to treat mental health conditions among military veterans.

Research and Development 81

Research and Development Clinical Trials Treatment Compliance 81

MMJ Recs

DECEMBER 17, 2023

Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. The program imposes strict limitations on the THC content in the prescribed cannabis, ensuring that it remains at a very low level.

Law 52

Law Dispensary Clinical Trials Programs 52

Canna Care Docs

JUNE 18, 2018

For those who might be exploring the benefits of cannabis or are considering its many therapeutic effects, Cannabidiol, often abbreviated as CBD is especially important for cannabis patients. CBD possess a wide array of therapeutic effects, without the psychoactive and intoxicating effects that are typically associated with cannabis.

Clinical Trials 75

Clinical Trials CBD Epilepsy Patients 75

Puff Puff Post

OCTOBER 3, 2019

Montefiore Medical Center in New York and GW Pharmaceuticals are examining the effects of a cannabis compound when administered to children on the autism spectrum. The cannabis compound referred to as cannabidivarin (CBDV) is a non-psychoactive chemical that does not cause a “high” when consumed.

Research and Development 94

Research and Development Epilepsy Clinical Trials Treatment 94

Veriheal

MAY 3, 2022

Cannabis use disorder (CUD) is often confused with frequent cannabis use , but CUD is significantly more worrisome. The outcomes and measures used throughout the trial included changes in CUD symptoms; anxiety and depressive symptoms; pain severity; and insomnia symptoms. Clinical Trial Sample Size.

Research and Development 95

Research and Development Clinical Trials Consumption Patients 95

Project CBD

AUGUST 6, 2019

Harvard University scientist Staci Gruber shared encouraging results from “the first open-label to double-blind clinical trial” assessing the impact of a high- CBD , low- THC sublingual tincture in patients who experience moderate anxiety. None of the participants had been using any cannabinoid-based products prior to this study.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

Cannabis Law Report

FEBRUARY 10, 2022

Despite Petitioners’ noble cause, the case turned on a technicality after the Court determined that the DEA’s letter stating that such psilocybin treatment was not allowed, the document that prompted the lawsuit, was not a “final” decision of the Attorney General that the Court had jurisdiction to review. Background. Psilocybin.

DEA 52

DEA Clinical Trials Policy Research and Development 52

Veriheal

NOVEMBER 17, 2020

Ohio is currently accepting petitions in an attempt to expand the list of qualifying conditions for medical cannabis. Ohio became the 25th state to legalize medical cannabis back on June 8 of 2016. Medical cannabis is now available to residents in Ohio who meet one of 22 qualifying conditions laid out by House Bill 523.

Conditions 98

Conditions Research and Development Pharmaceutical Clinical Trials 98

CannaMD

MAY 25, 2021

These findings could point to new cannabis-based therapies for both the healing of broken bones and the slowing of degenerative osteoporosis. A recent study documented bone healing in rodents with broken femoral bones, in which subjects were injected with a formula of either THC or CBD. THC, CBD & THE ECS. Find Out if You Qualify.

Marijuana 111

Marijuana Research and Development Clinical Trials THC 111

SpeedWeed

SEPTEMBER 4, 2021

The DEA published a new document in the Federal Register on September 2 requesting an increase in production for certain Schedule I and Schedule II substances so that it can initiate more research studies. . For cannabis, the ongoing restriction as a Schedule I substance will eventually come to an end. Some states in the U.S.

DEA 52

DEA Research and Development Clinical Trials Extraction 52

Cannabis Law Report

FEBRUARY 2, 2022

– Flora seeks approval to take their patent-pending, cannabinoid-based product through clinical trials under an EUA from INVIMA (Colombian FDA). This application comes on the heels of Colombia’s new legislation requiring insurance companies to cover cannabis prescriptions. “I About Flora Growth Corp.

Cannabinoids 52

Cannabinoids Clinical Trials Events Cultivation 52

CannaMD

OCTOBER 29, 2020

But, while contraband cannabis might not be a concern, the very real threat that candy poses to the American population is alarming. So this Halloween, we invite you to join us as CannaMD takes a brave look at five times candy – in all its high-glycemic glory –was way scarier than cannabis. Cannabis: 1. Cannabis: 2.

Research and Development 92

Research and Development Blood Pressure Data Clinical Trials 92

Project CBD

AUGUST 6, 2019

Harvard University scientist Staci Gruber shared encouraging results from “the first open-label to double-blind clinical trial” assessing the impact of a high- CBD , low- THC sublingual tincture in patients who experience moderate anxiety. None of the participants had been using any cannabinoid-based products prior to this study.

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

AUGUST 25, 2021

Acquisition Advances Company’s Strategic Plan Toward a Diversified Novel Drug Development Pipeline in Psychedelics and Medical Cannabis. Kotra taking on the role of leading the development of FSD Pharma’s drug development pipeline in Psychedelics and Medical Cannabis. www.fsdpharma.com. About Lucid Psycheceuticals.

Clinical Trials 111

Clinical Trials Research and Development Therapy Conditions 111

MedicalJane

JUNE 29, 2018

None of the approved drugs contain, or are derived from, the whole cannabis plant. The new drug is indicated for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. a Canada-based medical cannabis firm.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

Cannabis Law Report

NOVEMBER 16, 2019

Current barriers to patient access to medicinal cannabis in Australia. On 14 November 2019, the Senate referred an inquiry into the current barriers to patient access to medicinal cannabis in Australia to the Senate Community Affairs References Committee for inquiry and report by 12 February 2020.

Clinical Trials 58

Clinical Trials Access Medicine Patients 58

Cannabis Law Report

JULY 14, 2021

(“ImmunoFlex” ), today announced that it has completed and analyzed its clinical trial of 21 patients, aged 60 to 70 years. ImmunoFlex’s believes that the immune system changes observed in this clinical study are beneficial changes with the potential to improve immune system competence. Learn more at www.immunoflex.com.

Research and Development 105

Research and Development Clinical Trials Events Treatment 105

Veriheal

JUNE 7, 2021

It turns out that this blissful drug, MDMA, has the potential to be used effectively as a treatment for certain conditions- some of which are in urgent need of effective medical assistance. . MDMA has also reportedly been used with over 1,000 individuals in clinical trials , with no adverse effects to report. . What is MDMA?

Therapy 67

Therapy Treatment Conditions Clinical Trials 67

Puff Puff Post

OCTOBER 3, 2019

Montefiore Medical Center in New York and GW Pharmaceuticals are examining the effects of a cannabis compound when administered to children on the autism spectrum. The cannabis compound referred to as cannabidivarin (CBDV) is a non-psychoactive chemical that does not cause a “high” when consumed.

Research and Development 40

Research and Development Epilepsy Clinical Trials Treatment 40

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD.

Therapy 40

Therapy Compliance Compliance Clinical Trials 40

CannaMD

AUGUST 26, 2020

Find out more about the studies scientists reviewed – and why they think cannabis could help cocaine addiction – below! Current Cocaine Treatments. As researchers point out: There is no gold standard pharmacological treatment for dependence on cocaine. This lack of treatment is especially alarming given the U.N.

Therapy 98

Therapy CBD Research and Development Treatment 98

Cannabis Law Report

JUNE 9, 2022

Ukraine’s Health Minister Viktor Liashko announced on June 7 that the government had backed the bill that would legalize medical cannabis amid the war with Russia. We understand the number of people who will need medical treatment due to this exposure. “We understand the negative effects of war on mental health.

Seed-To-Sale 52

Seed-To-Sale Legalization Cultivation Medicine 52

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Patients using warfarin need to have their blood INR level tested after adding THC-containing cannabis to their regimen. How Do CBD Drug Interactions Occur? CBD and Glaucoma.

CBD 98

CBD THC Conditions Medicine 98

The Joint Blog

JANUARY 12, 2020

billion by 2023, according to the cannabis research firm Brightfield Group and noted by the AP. This year, it has sent warning letters to 22 companies citing violations such as making claims about therapeutic uses and treatment of disease in humans or animals or marketing CBD as a dietary supplement or food ingredient.

Pets 36

Pets CBD Clinical Trials Research and Development 36

Cannabis Law Report

JULY 9, 2022

For Jessica Thornton, who has lived with treatment-resistant depression since her senior year at high school, psychedelics represent a lifeline. I found that Johns Hopkins and other major research universities were doing clinical studies on psilocybin and treatment-resistant depression.”.

Microdosing 52

Microdosing Wellness and Beauty Research and Development Clinical Trials 52

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The popularity of medical cannabinoids (MCs) treatment is growing, as more countries enable MCs treatment for various indications in adults 1. The search included studies through 11-May-2020. Introduction.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

JANUARY 20, 2022

Eleusis designed ELE-Psilo, a proprietary psilocybin-based drug candidate that is formulated for IV infusion and in development for the treatment of depression. Eleusis secured an Innovation Passport Designation for ELE-Psilo in adult treatment-resistant depression under the U.K. II is a $287.5

Therapy 52

Therapy Research and Development Business Access 52

The Cannigma

DECEMBER 12, 2022

Scientists are hopeful that psychedelics might have more of a curative effect when it comes to mental health than many existing treatment options; meaning that unlike most psychiatric medications, psychedelics may be able to prompt long-term changes to our mental state with only a few doses. Are psychedelics safe?

History 119

History Microdosing Research and Development Clinical Trials 119

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions.[1]. Patients using warfarin need to have their blood INR level tested after adding THC-containing cannabis to their regimen. How Do CBD Drug Interactions Occur? CBD and Glaucoma.

CBD 52

CBD THC Conditions Medicine 52

Cannabis Law Report

JULY 24, 2019

Marketwatch report… Shares of cannabis company Curaleaf Holdings Inc. 321(g)(1), because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or intended to affect the structure or any function of the body.

CBD 51

CBD Tincture Pets Chronic Pain 51

Cannabis Law Report

JUNE 11, 2019

This article will examine how courts have responded to claims for cannabis, as an element of future care costs, in personal injury cases. These claims have occurred against a background of significant change with regards to the acceptance of cannabis, both medically and recreationally. Awards for Cannabis as a Future Care Cost.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

Cannabis Law Report

JULY 28, 2021

Validates Cepharanthine’s potential in treating various cancers with unsatisfactory treatment options. Advance to FDA IND-enabling studies to support human clinical studies. Previously the Company announced that it had secured FDA Orphan Drug Designation for cepharanthine in the treatment of esophageal cancer.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

FloridaMarijuana.net

OCTOBER 9, 2018

The cannabis plant has been used medicinally for a multitude of health issues, specifically chronic pain. The use of cannabis has been well-documented throughout historical and ancient times and well supported through the medical literature. Science now understands that the whole cannabis plant offers medicinal properties.

Terpenes 100

Terpenes Chronic Pain Strains Clinical Trials 100

CannaMD

MARCH 8, 2021

Prohibiting a medical marijuana treatment center from dispensing marijuana that exceeds a certain potency of tetrahydrocannabinol [p. Revising a provision relating to the potency of tetrahydrocannabinol in edibles dispensed by a medical marijuana treatment center [p.1, 2, line 32]. 2, line 38]. 1, line 12]. 2, line 26]. 2, line 26].

THC 116

THC Research and Development Treatment Patients 116